Camurus AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Camurus AB
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus’ clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.
/ 
Frequently asked questions
To buy Camurus AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Camurus AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Camurus AB is CAMX:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Camurus AB has its primary listing on NASDAQ OMX Stockholm. You can trade Camurus AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Camurus AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Camurus AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Camurus AB.